140 related articles for article (PubMed ID: 7417631)
1. Relative potency of amphetamine isomers in causing the serotonin behavioral syndrome in rats.
Sloviter RS; Damiano BP; Connor JD
Biol Psychiatry; 1980 Oct; 15(5):789-96. PubMed ID: 7417631
[TBL] [Abstract][Full Text] [Related]
2. Evidence that serotonin mediates some behavioral effects of amphetamine.
Sloviter RS; Drust EG; Connor JD
J Pharmacol Exp Ther; 1978 Aug; 206(2):348-52. PubMed ID: 308099
[TBL] [Abstract][Full Text] [Related]
3. Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives.
Bustamante D; Díaz-Véliz G; Paeile C; Zapata-Torres G; Cassels BK
Pharmacol Biochem Behav; 2004 Oct; 79(2):199-212. PubMed ID: 15501295
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation.
Simpson LL
J Pharmacol Exp Ther; 1975 Apr; 193(1):149-59. PubMed ID: 1133761
[TBL] [Abstract][Full Text] [Related]
5. Altered behavioral responses in 2,4-dichlorophenoxyacetic acid treated and amphetamine challenged rats.
Evangelista de Duffard AM; Bortolozzi A; Duffard RO
Neurotoxicology; 1995; 16(3):479-88. PubMed ID: 8584279
[TBL] [Abstract][Full Text] [Related]
6. The effects of stereoisomers of 2- and 9- aminobenzonorbornenes on food intake, brain serotonin concentration and monoamine oxidase activity in the rat.
Gray NM; Lu MC; Bhargava HN
J Pharmacol Exp Ther; 1982 Apr; 221(1):58-62. PubMed ID: 7062292
[TBL] [Abstract][Full Text] [Related]
7. 4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats.
Hegadoren KM; Greenshaw AJ; Baker GB; Martin-Iverson MT; Lodge B; Soin S
J Psychiatry Neurosci; 1994 Jan; 19(1):57-62. PubMed ID: 8148367
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Lane EL; Brundin P; Cenci MA
Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
[TBL] [Abstract][Full Text] [Related]
9. The effects of d- and l- amphetamine on fixed-interval and fixed-ratio behavior in tolerant and nontolerant rats.
Tilson HA; Sparber SB
J Pharmacol Exp Ther; 1973 Nov; 187(2):372-9. PubMed ID: 4748553
[No Abstract] [Full Text] [Related]
10. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.
Easton N; Steward C; Marshall F; Fone K; Marsden C
Neuropharmacology; 2007 Feb; 52(2):405-14. PubMed ID: 17020775
[TBL] [Abstract][Full Text] [Related]
11. Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies.
Fowler SC; Birkestrand B; Chen R; Vorontsova E; Zarcone T
Psychopharmacology (Berl); 2003 Nov; 170(2):167-77. PubMed ID: 12827349
[TBL] [Abstract][Full Text] [Related]
12. The effects of metoclopramide, sulpiride, and the stereoisomers of baclofen on amphetamine-induced behavior in the marmoset.
Ridley RM; Scraggs PR; Baker HF
Biol Psychiatry; 1980 Apr; 15(2):265-74. PubMed ID: 7191332
[TBL] [Abstract][Full Text] [Related]
13. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
[TBL] [Abstract][Full Text] [Related]
14. The increased release of 3H-5-hydroxytryptamine by d-para-methoxyamphetamine and d-amphetamine in vivo.
Tseng LF
Proc West Pharmacol Soc; 1976; 19():136-41. PubMed ID: 1036622
[No Abstract] [Full Text] [Related]
15. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1999 Oct; 291(1):19-30. PubMed ID: 10490882
[TBL] [Abstract][Full Text] [Related]
16. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
Morley KC; Cornish JL; Li KM; McGregor IS
Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
[TBL] [Abstract][Full Text] [Related]
17. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans.
Rush CR; Stoops WW; Hays LR; Glaser PE; Hays LS
J Pharmacol Exp Ther; 2003 Jul; 306(1):195-204. PubMed ID: 12676890
[TBL] [Abstract][Full Text] [Related]
18. Behavioral alterations in rats prenatally exposed to low doses of d-amphetamine.
Adams J; Buelke-Sam J; Kimmel CA; LaBorde JB
Neurobehav Toxicol Teratol; 1982; 4(1):63-70. PubMed ID: 7070570
[No Abstract] [Full Text] [Related]
19. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
Florin SM; Kuczenski R; Segal DS
J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine.
Simpson LL
J Pharmacol Exp Ther; 1980 Jun; 213(3):504-8. PubMed ID: 7205614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
